SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Centene Corporation Securities and Sets a Lead Plaintiff Deadline of September 8, 2025

Core Viewpoint - A class action lawsuit has been filed against Centene Corporation for allegedly providing misleading statements regarding its enrollment and morbidity rates, leading to a significant drop in stock price after the company withdrew its 2025 guidance [3][4]. Company Overview - Centene Corporation is facing legal action for allegedly disseminating materially false and misleading statements about its business performance during the period from December 12, 2024, to June 30, 2025 [1]. - The lawsuit claims that Centene's positive public statements were contradicted by the actual lower-than-expected market growth across 22 states, which constitutes 72% of the company's marketplace membership [3]. Financial Impact - Following the announcement of the withdrawal of 2025 guidance, Centene's stock price plummeted from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025, marking a decline of 40.4% [4]. - The company revised its guidance to approximately $1.8 billion, with an adjusted diluted EPS of $2.75, indicating a significant downward adjustment in expectations [3].